Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

US FDA Changing View Of Citizen Petition Response Time, Could Eliminate Serial Refiling

03 Oct 2018

• By Derrick Gingery

FDAEntrance_1200x675

Related Content

To Lower Drug Prices, Look At Generic Industry Health Rather Than FDA, Woodcock Says

25 Sep 2018

US FDA Amps Up "Name And Shame" Approach To Thwart Anti-Generic Tactics

03 Oct 2018

FDA To Implement Live Citizen Petition Status Updates

13 May 2016

Citizen Petitions Targeting ANDAs Recede, But Concerns Over Resources Remain

19 Aug 2016

Additional Topics

United States Generic Drugs Legal Issues Regulation FDA BioPharmaceutical

More from Generics

More from Products

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.